(Q35561680)

8 August 2017

1 reference

title

Cytokine regulation of pulmonary fibrosis in scleroderma (English)

1 reference

8 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

22 March 2024

author name string

Barbara White

2

1 reference

8 August 2017

Sergei P. Atamas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563355

22 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14563355

22 March 2024

publication date

1 December 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1359610103000601?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

https://api.elsevier.com/content/article/PII:S1359610103000601?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

Cytokine and Growth Factor Reviews

22 March 2024

published in

1 reference

8 August 2017

14

1 reference

8 August 2017

537-550

1 reference

8 August 2017

6

1 reference

Prevalence of scleroderma spectrum disorders in the general population of South Carolina

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Severe restrictive lung disease in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interstitial lung disease of systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

A new direction in the pathogenesis of idiopathic pulmonary fibrosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Alternative versus classical activation of macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Gene expression in bronchoalveolar lavage cells from scleroderma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Late CD8+ lymphocytic alveolitis after allogeneic bone marrow transplantation and chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Hapten-immune pulmonary interstitial fibrosis (HIPIF) in mice requires both CD4+ and CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Impairment of bleomycin-induced lung fibrosis in CD28-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

The differentiation and function of myofibroblasts is regulated by mast cell mediators

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Role of stem cell factor and monocyte chemoattractant protein-1 in the interaction between fibroblasts and mast cells in fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Elevated plasma histamine levels in systemic sclerosis (scleroderma).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Effect of histamine on proliferation of normal human adult lung fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Effect of histamine on collagen and collagen m-RNA production in human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Elevated levels of eosinophil major basic protein in the sera of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Eosinophils adhere to and stimulate replication of lung fibroblasts 'in vitro'.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Pulmonary capillary endothelial dysfunction in early systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Endothelin-1 secretion by alveolar macrophages in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Restricted T-cell antigen receptor repertoire in bronchoalveolar T cells from normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Thrombin upregulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C-gamma activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Investigation of type I and type III collagens of the lung in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Increased sensitivity of scleroderma fibroblasts in culture to stimulation of protein and collagen synthesis by serum

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Collagen synthesis in scleroderma: selection of fibroblast populations during subcultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Increased Expression of TGF-β Receptors by Scleroderma Fibroblasts: Evidence for Contribution of Autocrine TGF-β Signaling to Scleroderma Phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Deficient Smad7 expression: a putative molecular defect in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

C-myb, but not B-myb, upregulates type I collagen gene expression in human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Role of p38 MAPK in Transforming Growth Factor β Stimulation of Collagen Production by Scleroderma and Healthy Dermal Fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Expression of c-myc, c-myb, and c-sis in fibroblasts from affected and unaffected skin of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

c-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Characterization of the c-Myb-responsive region and regulation of the human type I collagen alpha 2 chain gene by c-Myb.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGF

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Fibroblast selection in scleroderma. An alternative model of fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Complex cytokine regulation of tissue fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

TGF-beta is a critical mediator of acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

TGF-beta 1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Response of scleroderma fibroblasts to various growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Transforming growth factor (TGF beta) decreases the proliferation of human bone marrow fibroblasts by inhibiting the platelet-derived growth factor (PDGF) binding

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Induction of heat shock protein 47 synthesis by TGF-beta and IL-1 beta via enhancement of the heat shock element binding activity of heat shock transcription factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Secretion and binding of transforming growth factor beta by scleroderma and normal dermal fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Spontaneous Activation of Transforming Growth Factor-β Gene Transcription in Broncho-Alveolar Mononuclear Cells of Individuals with Systemic Autoimmune Diseases with Lung Involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interleukin-4 regulates connective tissue growth factor expression in human lung fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Increased Plasma Levels of Platelet-Derived Growth Factor Activity in Patients with Progressive Systemic Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Thrombin stimulates the expression of PDGF in lung epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Depletion of protein kinase Cepsilon in normal and scleroderma lung fibroblasts has opposite effects on tenascin expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Thrombin promotes fibroblast proliferation during the early stages of experimental radiation pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interleukin-1 beta prevents the stimulatory effect of transforming growth factor-beta on collagen gene expression in human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Elevated expression of the genes encoding TNF-alpha and thromboxane synthase in leucocytes from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Enhanced production of interleukin-1 and tumor necrosis factor alpha by cultured peripheral blood monocytes from patients with scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Cytokine production and serum levels in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Increased interleukin-17 production in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Oncostatin M Stimulates Transcription of the Human α2(I) Collagen Gene via the Sp1/Sp3-binding Site

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Antagonistic effects of interferon-gamma and interleukin-4 on fibroblast cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interferon-gamma inhibits experimental renal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interferon-gamma and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Antagonistic effects of an alternative splice variant of human IL-4, IL-4delta2, on IL-4 activities in human monocytes and B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Alternative splice variants of cytokines: making a list

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Recombinant interferon-gamma in the treatment of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interleukin-4 acts as a potent stimulator for expression of monocyte chemoattractant JE/MCP-1 in mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Increased Expression of CD40 Ligand in Activated CD4+T Lymphocytes of Systemic Sclerosis Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Protection from pulmonary fibrosis in the absence of CCR2 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Chemotactic cytokines mediate leukocyte recruitment in fibrotic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Expression of C-C chemokines in bronchoalveolar lavage cells from patients with granulomatous lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900060-1

7 January 2021

Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma

56

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis

22 March 2024

57

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

Smooth muscle differentiation in scleroderma fibroblastic cells

22 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma

22 March 2024

70

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma

22 March 2024

113

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

Interleukin-1 inhibits the synthesis of collagen by fibroblasts

22 March 2024

134

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis

22 March 2024

141

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis

22 March 2024

155

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts

22 March 2024

156

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts

22 March 2024

160

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis

22 March 2024

178

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00060-1

22 March 2024

Identifiers

1 reference

8 August 2017

1 reference